AIRLINK 180.86 Increased By ▲ 0.76 (0.42%)
BOP 11.67 Decreased By ▼ -1.42 (-10.85%)
CNERGY 7.50 Increased By ▲ 0.02 (0.27%)
FCCL 46.07 Increased By ▲ 0.89 (1.97%)
FFL 16.26 Increased By ▲ 0.20 (1.25%)
FLYNG 27.24 Decreased By ▼ -0.19 (-0.69%)
HUBC 132.07 Decreased By ▼ -1.17 (-0.88%)
HUMNL 13.02 No Change ▼ 0.00 (0%)
KEL 4.57 Increased By ▲ 0.12 (2.7%)
KOSM 6.10 Increased By ▲ 0.13 (2.18%)
MLCF 59.17 Increased By ▲ 0.36 (0.61%)
OGDC 221.38 Increased By ▲ 2.79 (1.28%)
PACE 5.87 No Change ▼ 0.00 (0%)
PAEL 45.54 Increased By ▲ 2.92 (6.85%)
PIAHCLA 17.96 Increased By ▲ 1.46 (8.85%)
PIBTL 10.18 Increased By ▲ 0.26 (2.62%)
POWER 11.85 Decreased By ▼ -0.10 (-0.84%)
PPL 184.09 Increased By ▲ 1.01 (0.55%)
PRL 36.54 Increased By ▲ 1.21 (3.42%)
PTC 24.96 Increased By ▲ 0.62 (2.55%)
SEARL 101.23 Increased By ▲ 5.41 (5.65%)
SILK 1.17 Increased By ▲ 0.02 (1.74%)
SSGC 37.26 Decreased By ▼ -0.05 (-0.13%)
SYM 15.20 Decreased By ▼ -0.88 (-5.47%)
TELE 7.80 Decreased By ▼ -0.08 (-1.02%)
TPLP 10.64 Decreased By ▼ -0.20 (-1.85%)
TRG 60.56 Decreased By ▼ -0.38 (-0.62%)
WAVESAPP 10.82 Increased By ▲ 0.03 (0.28%)
WTL 1.32 Decreased By ▼ -0.01 (-0.75%)
YOUW 3.71 Decreased By ▼ -0.06 (-1.59%)
BR100 12,332 Increased By 117.4 (0.96%)
BR30 37,772 Increased By 332.8 (0.89%)
KSE100 116,200 Increased By 663.4 (0.57%)
KSE30 35,906 Increased By 248.2 (0.7%)

In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has successfully exported Centrum—a well-known multivitamin brand—from its manufacturing facility in Jamshoro to Kenya.

The pharmaceutical shared the development in its notice to the Pakistan Stock Exchange (PSX) on Wednesday.

“We are pleased to share that Haleon Pakistan Limited has successfully dispatched the first consignment of Centrum, manufactured at our facility in Jamshoro, to Kenya,” read the notice.

“This important milestone marks the beginning of an exciting journey, further enhancing our export operations in the year 2025. The successful shipment is a testament to our commitment to support the economy of Pakistan, opening new doors to growth opportunities in the international market,” it added

Moreover, the listed company lauded the role of relevant authorities and the Special Investment Facilitation Council (SIFC) for their support in facilitating this achievement.

Haleon Pakistan was incorporated in Pakistan as a publicly listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015.

The company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the company is Haleon plc. It is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over-the-counter health.

Pakistan’s pharmaceutical sector has recently made rapid strides in growing its presence in the global pharmaceutical and healthcare industries.

Last month, Citi Pharma Limited (CPHL) completed its first-ever export to the MENA region worth EUR 560,000.

“This export order was received based on the FDA accreditation that Citi Pharma has obtained (announced on 20th September 2024),” the pharmaceutical shared the development in a notice to the bourse.

Comments

200 characters
Tariq Qurashi Mar 13, 2025 11:20am
Well done Haleon and Citi Pharma. Keep up the good work!
thumb_up Recommended (0) reply Reply
Ahmed Waqar Mar 14, 2025 08:51am
Well done . It will be part of economic independence and less reliance on foreign products.
thumb_up Recommended (0) reply Reply